Welcome to our dedicated page for Swk Hldgs news (Ticker: SWKH), a resource for investors and traders seeking the latest updates and insights on Swk Hldgs stock.
SWK Holdings Corporation (Nasdaq: SWKH) is a life science focused specialty finance company that regularly reports on its financial performance, portfolio activity, and strategic transactions. As a provider of non-dilutive financing to small- and mid-sized commercial-stage healthcare companies, SWK’s news flow centers on its finance receivables portfolio, royalty monetization activity, and developments within its pharmaceutical development services operations.
Readers of this SWKH news page can expect updates on quarterly and annual financial results, including GAAP net income, segment-level non-GAAP metrics, effective yields on finance receivables, and changes in book value and tangible finance book value per share. The company frequently issues press releases in connection with its earnings reports and hosts conference calls to discuss its corporate and financial results.
SWK’s news also highlights portfolio transactions such as new term loans, expansions of existing credit facilities, sales and monetizations of royalty portfolios, and resolutions of nonaccrual positions or workout situations. Announcements have included the monetization of royalty assets, special dividends funded by those monetizations, and updates on loan payoffs and recoveries.
In addition, the company discloses strategic and corporate events, including its Agreement and Plan of Merger with Runway Growth Finance Corp., as well as updates on its pharmaceutical development subsidiaries. Investors following SWKH news gain insight into how SWK manages its life science finance portfolio, how non-GAAP measures relate to reported results, and how strategic transactions may affect stockholders. For those tracking the specialty finance and healthcare capital markets, this page offers a focused stream of company-issued information and regulatory news related to SWK Holdings Corporation.
Summary not available.
SWK Holdings Corporation (SWKH) announced significant corporate changes and financial results for Q4 2022. Jody Staggs has been named CEO, and Laurie Dotter will chair the board. The company expects quarterly operating expenses to decrease by over $1 million by Q3 2023. Q4 revenue fell 34.5% to $9.8 million, primarily due to a reduction in Pharmaceutical Development revenue. GAAP net income was $2.8 million, down from $6.3 million YoY, reflecting a pre-tax loss of $4.4 million. Investment assets increased by 25.4% to $237.9 million. The company remains focused on sustainable growth within the life sciences sector.
SWK Holdings Corporation (Nasdaq: SWKH), a specialty finance firm focused on life sciences, is set to host a conference call and live audio webcast on April 3, 2023, at 10:00 a.m. ET. The call will cover the corporate and financial results for the fourth quarter and full year of 2022. Interested investors can participate by calling (844) 378-6488 (U.S.) or (412) 317-1079 (International), or by accessing the webcast on the company's website. SWK specializes in non-dilutive financing for small- and mid-sized healthcare companies, providing flexible funding solutions ranging from $5.0 million to $25.0 million.
SWK Holdings Corporation (SWKH) announced the appointment of Jerry Albright to its Board of Directors, effective March 15, 2023, replacing Wendy DiCicco, who opted not to seek re-election due to external commitments. Mr. Albright brings extensive experience from his roles at the Teacher Retirement System of Texas and as managing partner at ADIM, LLC. His expertise is expected to enhance SWK's strategic goals in providing non-dilutive financing for small and mid-sized healthcare companies. The transition is aimed at maximizing SWK’s position in the market amid favorable capital dynamics.
DEWALT, a Stanley Black & Decker brand, will unveil innovative products at the World of Concrete Trade Show from January 17-19 in Las Vegas. Key launches include the 60V MAX* Cordless SDS MAX Chipping Hammer and 60V MAX* Cordless Breaker Hammer, both designed for heavy-duty demolition, available in July 2023. Also featured are the 60V MAX* Large Angle Grinder and TOUGHSYSTEM® 2.0 Dual Port Charger, scheduled for release in June and February 2023, respectively. Additional offerings include a 10 Gallon Dust Extractor and the PURE220+™ Premium Epoxy Anchor.
SWK Holdings Corporation (Nasdaq: SWKH) has officially named Jody Staggs as Chief Executive Officer, effective January 1, 2023, following his role as interim CEO since September 2022. Staggs' leadership has already facilitated multiple financing initiatives and improvements to the company's credit facility. Additionally, Laurie Dotter has been appointed Chair of the Board, contributing her extensive experience from various investment firms. Staggs emphasized a focus on optimizing capital structure and enhancing non-dilutive financial offerings for small and mid-sized life science companies.
SW K Holdings Corporation (Nasdaq: SWKH) announced a significant amendment to its Loan and Security Agreement with Cadence Bank, boosting its credit facility to $35 million, with an option to increase to $50 million. The new terms offer a lower interest rate of SOFR plus 2.65% and set a maturity date of September 30, 2025. This enhancement is part of SWK's strategy to optimize its capital structure and respond to rising interest in its non-dilutive financing solutions aimed at small- and mid-sized life sciences companies.
sbLiftOff, a mergers and acquisitions advisory firm, announced the appointment of Army veteran Branden Irvine as Director of Sales and Marketing. Irvine, a Bronze Star awardee, brings extensive experience from top brands including Stanley Black and Decker. His leadership aims to enhance sbLiftOff's services for government contracting and founder-led businesses. The firm specializes in mergers and acquisitions, particularly assisting veteran-owned businesses. The announcement highlights Irvine's commitment to supporting companies throughout their growth and acquisition journeys.
SWK Holdings Corporation (Nasdaq: SWKH) reported a 195% increase in GAAP net income to $6.6 million or $0.51 per diluted share for Q3 2022. Revenue rose 42.4% year-over-year to $13.6 million, driven by milestone revenue from its partnership with Cara Therapeutics. The finance portfolio effective yield was 14.3%, with a realized yield of 17.5%. The company closed three transactions totaling $57.5 million and repurchased 34,463 shares for $0.6 million. Notably, non-GAAP adjusted net income was $8.3 million, a 94.8% increase over the previous year.
SWK Holdings Corporation (NASDAQ: SWKH) will host a conference call on November 10, 2022, at 10:00 a.m. ET to discuss its third quarter 2022 financial results. The call can be accessed via phone or audio webcast, with an archive available for 90 days post-event. SWK Holdings is a specialty finance company focused on small- and mid-sized healthcare companies, providing non-dilutive financing solutions that typically range from $5 million to $25 million. The Company aims to create long-term value for stakeholders through unique financing structures.